CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot aims to tame tough liver virus
Disease control OngoingThis study is testing a new injectable drug called brelovitug (BJT-778) to control chronic Hepatitis D virus infection. About 150 participants will receive either a weekly shot, a monthly shot, or be in a group that waits 24 weeks before starting treatment. The main goal is to se…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Tracking Real-World results for hepatitis d treatment
Disease control OngoingThis study collects long-term safety and effectiveness data from people with chronic hepatitis D who are being treated with bulevirtide. It follows 170 participants who are either already receiving the medication or are scheduled to start treatment. The main goal is to monitor li…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC